Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study

Neurology

Volumn 59, Issue 9, 2002, Pages 1375-1380

  Prins, N D ^a   Den Heijer, T ^a   Hofman, A ^a   Koudstaal, P J ^a   Jolles, J ^b   Clarke, R ^c   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN INJURY; COGNITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIINFARCT DEMENTIA; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY;

EID: 0037069282     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000032494.05619.93     Document Type: Article

References (36)

1. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
2. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353:1586-1587.
3. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
4. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
5. Riggs KM, Spiro A, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-314.
6. Budge M, Johnston C, Hogervorst E, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann NY Acad Sci 2000;903:407-410.
7. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-313.
8. Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997;94:5923-5928.
9. Diaz-Arrastia R. Hyperhomocysteinemia: A new risk factor for Alzheimer disease? Arch Neurol 1998;55:1407-1408.
10. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 2001;56:1539-1545.
11. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
12. Hofman A, van Laar A, Klein F, Valkenburg H. Coffee and cholesterol (letter). N Engl J Med 1983;309:1248-1249.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: The Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 1976;6:439-449.
15. Nexo E, Engbaek F, Ueland PM, et al. Evaluation of novel assays in clinical chemistry: Quantification of plasma total homocysteine. Clin Chem 2000;46:1150-1156.
16. Bohnen N, Twijnstra A, Jolles J. Performance in the Stroop color word test in relationship to the persistence of symptoms following mild head injury. Acta Neurol Scand 1992;85:116-121.
17. Hammes J. De Stroop Kleur-Woord Test. Lisse: Swets & Zeitlinger, 1971.
18. Lezak MD. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press, 1995.
19. Luteijn F, van der Ploeg F. Groninger Intelligentie Test. Lisse: Swets & Zeitlinger, 1983.
20. Houx PJ, Vreeling FW, Jolles J. Rigorous health screening reduces age effect on memory scanning task. Brain Cogn 1991;15:246-260.
21. Sternberg S. Memory-scanning: Mental processes revealed by reaction-time experiments. Am Sci 1969;57:421-457.
22. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112:201-210.
23. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-151.
24. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam scan study. Stroke 2002;33:21-25.
25. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997;96:1432-1437.
26. UNESCO. International Standard Classification of Education (ISCED) (Report No: IGC/3). Paris: UNESCO, 1976.
27. Radloff L. The CES-D Scale. A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
28. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin Lab 2000;46:53-55.
29. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
30. Clarke R, Woodhouse P, Ulvik A, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 1998;44:102-107.
31. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331-339.
32. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 1999;150:283-289.
33. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
34. Breteler MM, Bots ML, Ott A, Hofman A. Risk factors for vascular disease and dementia. Haemostasis 1998;28:167-173.
35. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71:614S-620S.
36. White AR, Huang X, Jobling MF, et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem 2001;76:1509-1520.